Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction

AIMS: Everolimus-eluting stents (EES) were superior to sirolimus-eluting stents (SES) in a dedicated myocardial infarction trial, a finding that was not observed in trials with low percentages of ST-elevation myocardial infarction (STEMI). Therefore, this study sought to investigate the influence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Velders, M. A., van Boven, A. J., Brouwer, J., Smits, P. C., van ’t Hof, A. W. J., de Vries, C. J., Queré, M., Hofma, S. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954924/
https://www.ncbi.nlm.nih.gov/pubmed/24522952
http://dx.doi.org/10.1007/s12471-014-0525-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954924/
https://www.ncbi.nlm.nih.gov/pubmed/24522952
http://dx.doi.org/10.1007/s12471-014-0525-0

Ejemplares similares